NCT04115215

Brief Summary

Cognitive and mobility impairments are critical contributors to dementia and disability in older adults, and can be caused by neurodegenerative and neurovascular changes at the pre-frontal (PF) brain areas. In a previous technological project funded by ISCiii, the investigators adapted a non-invasive, point-of-care optical methods (fNRIS/fDCS technology) to study PF metabolism and blood flow activation during cognitive and motor tasks, in older adults with and without cognitive impairment. These methods are sensitive to change after physical exercise (PE) and after selectively and safely stimulating PF areas with electrical transcranial direct current stimulation (tCS). PE and tCS have shown benefits for cognition and mobility in the elderly, but their prolonged effect on PF hemodynamic activation has not been studied. Understanding the specific action of these interventions on the brain, and their clinical cognitive and motor impact, is key to fine-tune appropriate treatment strategies. The FRONT STAGE project aims to compare, through a 3 arms single-blind randomized clinical trial, the impact of a 10 weeks, 1 hour/week program of PE (arm 1) Vs PE+tCS (arm 2) and Vs a control group (arm 3, healthy aging sessions and control of cardiovascular risk factors). The PE program is already implemented in primary care, as part of another previous project of the investigators' research group. Outcomes will include the optical measurement of PF metabolism and blood flow and clinical measures of cognitive and physical function. Front STAGE project will recruit 93 older adults with cognitive impairment and slow gait, but without dementia or disability in the activities of daily living (N=31 per arm). They will receive a comprehensive geriatric assessment at baseline, together with the optical, cognitive and physical measures, and will be follow-up at 3 and 6 months. Weekly physical activity through accelerometry will be controlled in analyses. FRONT STAGE project centered on aging and the prevention of dementia and disability, will provide, translationally, more evidence to support and enlarge the clinical application of these interventions, and will contribute to foster further research in this field.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 3, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

March 23, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2023

Completed
Last Updated

July 2, 2021

Status Verified

June 1, 2021

Enrollment Period

3 years

First QC Date

September 30, 2019

Last Update Submit

June 30, 2021

Conditions

Keywords

Older adultsCognitive impairmentMotoric Cognitive Risk SyndromePhysical disfunctionMulti-component physical exercise programTranscranial electrical stimulation

Outcome Measures

Primary Outcomes (1)

  • Changes in hemoglobin oxygenation during functional tasks, as measured using fNIRS+fDCS optical techniques.

    Our primary outcome will be prefrontal hemoglobin oxygenation during a) cognitive tests, such as phonetic verbal fluency and calculations (2-forward and 3-backward counting), b) normal gait, c) dual task (walking while counting). All the measures will be controlled for extra-cerebral and systemic contributions due to variations in heart-rate, oxygen saturation, respiration rate and end-tidal carbondioxide. Various measures such as those derived from accelerometers to account for potential motion artifacts will be also utilized, followed by a multi-subject analysis.

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

Secondary Outcomes (7)

  • Cognitive executive function tests - Phonetic Verbal Fluency

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • Rey Auditory Verbal Learning Test (RAVLT)

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • Cognitive executive function tests - SDMT

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • Physical function

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • Motor function

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • +2 more secondary outcomes

Other Outcomes (12)

  • Spatial temporal parameters of gait

    Baseline (prior to intervention), 3 and 6 months after completion of the intervention.

  • Total time of daily physical activity

    7 consecutive days (arms 2 & 3) just after the start of the intervention.

  • Clinical comorbidity

    Baseline.

  • +9 more other outcomes

Study Arms (3)

Arm 1

EXPERIMENTAL

Physical exercise (PE)

Behavioral: Physical exercise (PE)

Arm 2

EXPERIMENTAL

Transcranial current stimulation (tCS)

Behavioral: Physical exercise (PE)Device: Transcranial current stimulation (tCS)

Control

ACTIVE COMPARATOR

Educational sessions on healthy aging

Other: Control

Interventions

This arm includes 10 sessions of multi-component exercise sessions (including aerobic, resistance, flexibility, dual-tasking) of 1 hour/week of functional group exercise, directed to foster empowerment for subsequent continuation of exercise in community-dwelling older adults referred by primary care to a geriatrician and an expert physical therapist. Participants will receive a leaflet with instructions to perform five strength-based exercises and instructors will recommend participants to perform the exercises and walk at least 15 minutes daily.

Arm 1Arm 2

This arm includes 1 application/week for 10 weeks during PE, through an adapted commercial helmet. Transcranial current stimulation (tCS) is a neural stimulation technique based on electrical stimulation of selected parts of the brain with direct or alternated electrical current (tDCS or tACS) of very low intensity of 1,5 milliamps (mA), using one or more electrodes placed on the skull. tCS is non-invasive (no surgical procedures) and it is painless, as applied in the proposed protocols.

Arm 2
ControlOTHER

Participants of similar profile, randomized to the control group, will undergo weekly 30 minutes educational sessions on healthy aging, including relevant aspects of nutrition, self-care, physical activity, plus measurement of blood pressure, heart rate and peripheral oxygen Hb saturation. These participants will be offered to join the PE program after the 6-months follow-up (end of the study).

Control

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • older adults (65 years or older)
  • with Motoric Cognitive Risk Syndrome
  • characterized by impaired cognition (which in our case will be confirmed with a Spanish version of the Montreal cognitive Assessment (MOCA), score between 26 and 21)
  • mobility impairment (measured as slow gait speed\<0.8 m/s)
  • without diagnosed clinical neurological or psychiatric diseases
  • with a preserved functional status for the activities of daily living
  • who can walk without help from third parties

You may not qualify if:

  • a diagnosis of dementia
  • advanced/terminal disease (life expectancy\<1 year)
  • contraindications to exercise and tCS
  • unwilling to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

The Institute of Photonic Sciences (ICFO)

Castelldefels, Barcelona, 08860, Spain

Location

Hospital Universitario La Ribera

Alzira, Valencia, 46600, Spain

Location

Institut Català de la Salut

Barcelona, 08004, Spain

Location

Parc Sanitari Pere Virgili

Barcelona, 08023, Spain

Location

Fundació Ictus

Barcelona, 08036, Spain

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

ExerciseTranscranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaElectric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Marco Inzitari, PhD

    Parc Sanitari Pere Virgili - Vall d'Hebron Institute of Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The investigators performing the follow-up assessments will be blind to randomization. In light of the difficulty to guarantee a complete blinding, these investigators will record if blinding is disclosed by participants during the interview.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2019

First Posted

October 3, 2019

Study Start

March 23, 2020

Primary Completion

March 23, 2023

Study Completion

March 23, 2023

Last Updated

July 2, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations